The 2024 edition of the Transcatheter Cardiovascular Therapeutics (TCT) conference once again highlighted significant innovations in cardiovascular care. This year’s event in Washington, D.C., featured company updates on all types of technologies, including heart valves, access and closure devices, drug-eluting implants, intravascular lithotripsy (IVL), renal denervation (RDN) and more. Some of the biggest names in […]
HeartFlow
HeartFlow data supports AI plaque analysis
HeartFlow announced positive seven-year data supporting the use of its AI-enabled fractional flow reserve computed tomography (FFRCT) and Plaque Analysis. This study assessed long-term risk of coronary artery disease (CAD) in clinically stable, symptomatic patients. Outcomes showed that the HeartFlow platform provides clinicians with the insights needed to anticipate and mitigate adverse events. That includes myocardial infarctions […]
HeartFlow unveils next-gen plaque analysis AI
HeartFlow announced today that it introduced its next-generation HeartFlow Plaque Analysis with an interactive experience. The company says its upgraded platform is the only plaque analysis tool fully integrated with fractional flow reserve derived from CT (FFRCT) — when FFRCT is performed. This delivers impactful insights to enhance clinical decision-making and enable personalized treatment plans. HeartFlow’s […]
HeartFlow earns reimbursement win for AI-based coronary solutions
HeartFlow announced today that the American Medical Association (AMA) transitioned reimbursement codes for its coronary artery disease assessment. The AMA changed the non-invasive, AI-based FFRCT treatment to a Category I Current Procedural Terminology (CPT) code. It went into effect on Jan. 1, 2024. Mountain View, California-based HeartFlow says the new code supports FFRCT as the […]
HeartFlow hits 250,000-patient mark
HeartFlow announced today that it surpassed 250,000 patients receiving its FFRCT Analysis for non-invasively diagnosing coronary artery disease. FFRCT Analysis and coronary computed tomography angiography (CCTA), provide an alternative to traditional ischemia testing methods. These methods include stress EKG, stress ECG, SPECT, PET and more. According to HeartFlow, these methods can result in false negatives […]
Data supports portfolio of HeartFlow precision coronary care solutions
HeartFlow today announced positive results from clinical studies evaluating its portfolio of coronary care technologies. Mountain View, California-based HeartFlow said the studies demonstrate the accuracy, utility and efficiency of its portfolio. The RevealPlaque, Decode and Smart-CT studies looked at the company’s coronary computed tomography angiography (CCTA)-based systems. HeartFlow presented results at the Society of Cardiovascular […]
How did medtech SPAC mergers fare?
Over the past few years, special purpose acquisition corporations (SPACs) have found their way into the medtech space. These businesses — built to bring private companies public — raise initial public offerings (IPOs). They then go and acquire existing companies, taking them public in the process. The value of these mergers varies, but some in […]
HeartFlow closes $215M Series F funding round
HeartFlow announced today that it closed a $215 million Series F funding round led by Bain Capital Life Sciences. New investor Janus Henderson Investors also contributed to the round. Participating existing investors included Baillie Gifford, Capricorn Investment Group, Hayfin Capital Management, HealthCor, Martis Capital, USVP and Wellington Management. J.P. Morgan acted as the sole placement […]
FDA clears HeartFlow’s AI-powered analysis tech
HeartFlow announced that the FDA granted 510(k) clearance to its AI-powered Plaque analysis and Roadmap Analysis products. Mountain View, California-based HeartFlow designed its technology around coronary computed tomography angiography (CCTA). It now offers non-invasive coronary artery anatomy, physiology and plaque information based on CCTA. The company said in a news release that it is the […]
The biggest medtech personnel moves so far in 2022
In the ever-changing world of medtech, those who are leading the companies are bound to move around a bit. At the end of last year, we compiled a list of medtech’s biggest personnel changes in 2021. So far in 2022, we’ve already seen a slew of major moves involving some of the space’s most powerful […]
HeartFlow announces new CEO
HeartFlow announced today that John Farquhar has been appointed as the company’s president and CEO, effective today. Farquhar, a former Medtronic executive, was appointed as COO of HeartFlow in August 2021 and has served as the company’s president and a member of the board since Jan. 1, 2022. According to a news release, co-founder and […]
